Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)
Clinical trial NCT04336722 · COMPLETED
Trial details
- NCT number
- NCT04336722
- Sponsor
- Albireo, an Ipsen Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-08
- Primary completion
- 2026-06-22
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.